Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
10/28/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $11,826,966 | $6,287,503 | $4,789,035 | $5,523,680 |
| - Cash | $338,341 | $297,304 | $264,192 | $242,077 |
| + Debt | $1,489,491 | $1,419,991 | $1,958,253 | $1,416,569 |
| Enterprise Value | $12,978,116 | $7,410,190 | $6,483,096 | $6,698,172 |
| Revenue | $156,719 | $452,049 | $131,612 | $226,576 |
| % Growth | -65.3% | 243.5% | -41.9% | – |
| Gross Profit | $154,381 | $447,898 | $130,112 | $222,746 |
| % Margin | 98.5% | 99.1% | 98.9% | 98.3% |
| EBITDA | -$94,378 | $150,233 | -$120,003 | -$80,503 |
| % Margin | -60.2% | 33.2% | -91.2% | -35.5% |
| Net Income | -$128,606 | $123,551 | -$146,938 | -$104,349 |
| % Margin | -82.1% | 27.3% | -111.6% | -46.1% |
| EPS Diluted | -0.8 | 0.68 | -0.93 | -0.66 |
| % Growth | -217.6% | 173.1% | -40.9% | – |
| Operating Cash Flow | -$131,437 | $151,338 | -$150,775 | -$116,139 |
| Capital Expenditures | -$3,306 | -$14,269 | -$12,577 | -$25,497 |
| Free Cash Flow | -$134,743 | $137,069 | -$163,352 | -$141,636 |